Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891540640> ?p ?o ?g. }
- W2891540640 endingPage "1769" @default.
- W2891540640 startingPage "1763" @default.
- W2891540640 abstract "Osteosarcoma is the most common primary bone malignancy and arises primarily in the metaphyseal ends of long bones in children and adolescents. m iR-590 has been found to have anti-tumor effects in many other cancers. However, the role of miR-590-3p in osteosarcoma is poorly understood. In this study, we show that miR-590-3p was significantly decreased both in osteosarcoma tissues and cell lines, suggesting a potential role of miR-590-3p in osteosarcoma. Over-expression of miR-590-3p inhibited U2OS cell viability as shown by the CCK-8 assay and clonogenic assay. Ki-67 immunofluorescence staining and cell cycle analysis revealed that up-regulation of miR-590-3p inhibited U2OS cell proliferation. Transfection with miR-590-3p mimics suppressed PCNA, Cyclin D1 and CDK4 expression and increased p53 and p21 expression. In addition, U2OS cells transfected with miR-590-3p mimics exhibited reduced cell invasion and migration, characterized by the wound healing assay and transwell assay. Furthermore, bioinformatics analysis demonstrated that SOX9 was a potential target of miR-590-3p. SOX9 was up-regulated in osteosarcoma tissues. Transfection with miR-590-3p mimics markedly suppressed SOX9 expression both at the mRNA level and protein level. Dual luciferase assay validated the direct binding site of miR-590-3p on SOX9. Exogenous SOX9 expression in U2OS cells at least partially reversed the effects of miR-590-3p in U2OS cells. Enforced SOX9 expression restored cell viability in osteosarcoma cells transfected with miR-590-3p mimics. In addition, over-expression of SOX9 restored decreased cell metastasis properties caused by transfection with miR-590-3p mimics in osteosarcoma cells. In summary, these results indicated that miR-590-3p is an anti-cancer miRNA that can inhibit proliferation and metastasis in osteosarcoma cells. Our findings provide a novel insight into the biological function of miR-590-3p in osteosarcoma and SOX9 may be a potential therapeutic target for osteosarcoma." @default.
- W2891540640 created "2018-09-27" @default.
- W2891540640 creator A5006589620 @default.
- W2891540640 creator A5024416999 @default.
- W2891540640 creator A5062460476 @default.
- W2891540640 creator A5064252569 @default.
- W2891540640 creator A5083815488 @default.
- W2891540640 creator A5085090414 @default.
- W2891540640 date "2018-11-01" @default.
- W2891540640 modified "2023-10-06" @default.
- W2891540640 title "miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9" @default.
- W2891540640 cites W1882985910 @default.
- W2891540640 cites W1896572732 @default.
- W2891540640 cites W1967915040 @default.
- W2891540640 cites W1980088710 @default.
- W2891540640 cites W1986756287 @default.
- W2891540640 cites W1996543107 @default.
- W2891540640 cites W1996588196 @default.
- W2891540640 cites W1996602180 @default.
- W2891540640 cites W1999628666 @default.
- W2891540640 cites W2010623582 @default.
- W2891540640 cites W2018596602 @default.
- W2891540640 cites W2025917129 @default.
- W2891540640 cites W2047512035 @default.
- W2891540640 cites W2054148405 @default.
- W2891540640 cites W2060106580 @default.
- W2891540640 cites W2075839911 @default.
- W2891540640 cites W2078849828 @default.
- W2891540640 cites W2083463213 @default.
- W2891540640 cites W2088067286 @default.
- W2891540640 cites W2095059750 @default.
- W2891540640 cites W2096262427 @default.
- W2891540640 cites W2097952624 @default.
- W2891540640 cites W2128482976 @default.
- W2891540640 cites W2135078386 @default.
- W2891540640 cites W2138769440 @default.
- W2891540640 cites W2139619092 @default.
- W2891540640 cites W2149699310 @default.
- W2891540640 cites W2149748804 @default.
- W2891540640 cites W2153301608 @default.
- W2891540640 cites W2593764350 @default.
- W2891540640 cites W2739216367 @default.
- W2891540640 doi "https://doi.org/10.1016/j.biopha.2018.06.124" @default.
- W2891540640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30257395" @default.
- W2891540640 hasPublicationYear "2018" @default.
- W2891540640 type Work @default.
- W2891540640 sameAs 2891540640 @default.
- W2891540640 citedByCount "42" @default.
- W2891540640 countsByYear W28915406402019 @default.
- W2891540640 countsByYear W28915406402020 @default.
- W2891540640 countsByYear W28915406402021 @default.
- W2891540640 countsByYear W28915406402022 @default.
- W2891540640 countsByYear W28915406402023 @default.
- W2891540640 crossrefType "journal-article" @default.
- W2891540640 hasAuthorship W2891540640A5006589620 @default.
- W2891540640 hasAuthorship W2891540640A5024416999 @default.
- W2891540640 hasAuthorship W2891540640A5062460476 @default.
- W2891540640 hasAuthorship W2891540640A5064252569 @default.
- W2891540640 hasAuthorship W2891540640A5083815488 @default.
- W2891540640 hasAuthorship W2891540640A5085090414 @default.
- W2891540640 hasConcept C104317684 @default.
- W2891540640 hasConcept C117262875 @default.
- W2891540640 hasConcept C145059251 @default.
- W2891540640 hasConcept C1491633281 @default.
- W2891540640 hasConcept C150194340 @default.
- W2891540640 hasConcept C153911025 @default.
- W2891540640 hasConcept C185592680 @default.
- W2891540640 hasConcept C199835354 @default.
- W2891540640 hasConcept C2777760704 @default.
- W2891540640 hasConcept C2778486617 @default.
- W2891540640 hasConcept C29537977 @default.
- W2891540640 hasConcept C502942594 @default.
- W2891540640 hasConcept C53227056 @default.
- W2891540640 hasConcept C54009773 @default.
- W2891540640 hasConcept C54355233 @default.
- W2891540640 hasConcept C55493867 @default.
- W2891540640 hasConcept C62112901 @default.
- W2891540640 hasConcept C81885089 @default.
- W2891540640 hasConcept C86803240 @default.
- W2891540640 hasConceptScore W2891540640C104317684 @default.
- W2891540640 hasConceptScore W2891540640C117262875 @default.
- W2891540640 hasConceptScore W2891540640C145059251 @default.
- W2891540640 hasConceptScore W2891540640C1491633281 @default.
- W2891540640 hasConceptScore W2891540640C150194340 @default.
- W2891540640 hasConceptScore W2891540640C153911025 @default.
- W2891540640 hasConceptScore W2891540640C185592680 @default.
- W2891540640 hasConceptScore W2891540640C199835354 @default.
- W2891540640 hasConceptScore W2891540640C2777760704 @default.
- W2891540640 hasConceptScore W2891540640C2778486617 @default.
- W2891540640 hasConceptScore W2891540640C29537977 @default.
- W2891540640 hasConceptScore W2891540640C502942594 @default.
- W2891540640 hasConceptScore W2891540640C53227056 @default.
- W2891540640 hasConceptScore W2891540640C54009773 @default.
- W2891540640 hasConceptScore W2891540640C54355233 @default.
- W2891540640 hasConceptScore W2891540640C55493867 @default.
- W2891540640 hasConceptScore W2891540640C62112901 @default.
- W2891540640 hasConceptScore W2891540640C81885089 @default.
- W2891540640 hasConceptScore W2891540640C86803240 @default.